Chun Xia Liu

435 total citations
12 papers, 286 citations indexed

About

Chun Xia Liu is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Chun Xia Liu has authored 12 papers receiving a total of 286 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 6 papers in Oncology and 4 papers in Molecular Biology. Recurrent topics in Chun Xia Liu's work include Immune cells in cancer (5 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Sarcoma Diagnosis and Treatment (2 papers). Chun Xia Liu is often cited by papers focused on Immune cells in cancer (5 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Sarcoma Diagnosis and Treatment (2 papers). Chun Xia Liu collaborates with scholars based in China, United States and Australia. Chun Xia Liu's co-authors include Li Pang, Junwen M. Hu, Lan Yang, Wei Liang, Xue Li Wang, Hong Zou, Yun Zhao Chen, Jin Jiang, Xiao Cui and Xi Shen and has published in prestigious journals such as Carcinogenesis, Medicine and Oncotarget.

In The Last Decade

Chun Xia Liu

12 papers receiving 285 citations

Peers

Chun Xia Liu
Chun Xia Liu
Citations per year, relative to Chun Xia Liu Chun Xia Liu (= 1×) peers Yun Zhao Chen

Countries citing papers authored by Chun Xia Liu

Since Specialization
Citations

This map shows the geographic impact of Chun Xia Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chun Xia Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chun Xia Liu more than expected).

Fields of papers citing papers by Chun Xia Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chun Xia Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chun Xia Liu. The network helps show where Chun Xia Liu may publish in the future.

Co-authorship network of co-authors of Chun Xia Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Chun Xia Liu. A scholar is included among the top collaborators of Chun Xia Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chun Xia Liu. Chun Xia Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Yuan, Xin, Yi Ren, Xue Li Wang, et al.. (2021). Cytokine-induced killer cells/dendritic cells and cytokine-induced killer cells immunotherapy for the treatment of esophageal cancer. Medicine. 100(13). e24519–e24519. 11 indexed citations
2.
Liang, Wei, Yu Xie, Xin Yuan, et al.. (2020). Distribution and prognostic impact of M1 macrophage on esophageal squamous cell carcinoma. Carcinogenesis. 42(4). 537–545. 13 indexed citations
3.
Yuan, Xin, Ya Li, Yu Xie, et al.. (2020). Tumor-associated macrophage polarization promotes the progression of esophageal carcinoma. Aging. 13(2). 2049–2072. 31 indexed citations
4.
Yuan, Xin, Yu Xie, Xue Li Wang, et al.. (2020). Bioinformatics-based screening of key genes for transformation of liver cirrhosis to hepatocellular carcinoma. Journal of Translational Medicine. 18(1). 43 indexed citations
5.
Liang, Wei, Xue Li Wang, Kai Liu, et al.. (2020). HLA-DR Regulates Macrophage Phenotypic Transformation and Affects Malignant Behavior in Esophageal Squamous Cell Carcinoma. SSRN Electronic Journal. 1 indexed citations
6.
Hu, Junwen M., Wei Liang, Xue Li Wang, et al.. (2018). HLA-DQB1*03 and DRB1*07 Alleles Increase the Risk of Cervical Cancer Among Uighur and Han Women in Xinjiang, China. Future Oncology. 14(20). 2005–2011. 2 indexed citations
7.
Hu, Junwen M., Kai Liu, Xian Jiang, et al.. (2017). CD163 as a marker of M2 macrophage, contribute to predict aggressiveness and prognosis of Kazakh esophageal squamous cell carcinoma. Oncotarget. 8(13). 21526–21538. 114 indexed citations
8.
Hu, Junwen M., Kai Liu, Xian Jiang, et al.. (2016). The increased number of tumor-associated macrophage is associated with overexpression of VEGF-C, plays an important role in Kazakh ESCC invasion and metastasis. Experimental and Molecular Pathology. 102(1). 15–21. 30 indexed citations
9.
Hu, Junwen M., Qi Sun, Ling Li, et al.. (2014). Human leukocyte antigen-DRB1*1501 and DQB1*0602 alleles are cervical cancer protective factors among Uighur and Han people in Xinjiang, China.. PubMed. 7(9). 6165–71. 14 indexed citations
10.
Liu, Chun Xia, et al.. (2009). Synthesis of Layered Double Hydroxides with Novel Morphologies. Journal of Dispersion Science and Technology. 30(2). 174–177. 1 indexed citations
11.
Pang, Li, Bin Chang, Hong Zou, et al.. (2008). Alveolar Soft Part Sarcoma: A Bimarker Diagnostic Strategy Using TFE3 Immunoassay and ASPL-TFE3 Fusion Transcripts in Paraffin-Embedded Tumor Tissues. Diagnostic Molecular Pathology. 17(4). 245–252. 23 indexed citations
12.
Chang, Bin, Li Pang, Qi Yan, et al.. (2008). PAX—FKHR Fusion Genes and AChR-γ in Chinese Patients With Rhabdomyosarcoma: Diagnosis Using Formalin-Fixed Archival Tissues. International Journal of Surgical Pathology. 17(1). 6–15. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026